Clinical Trials Logo

Common Bile Duct Diseases clinical trials

View clinical trials related to Common Bile Duct Diseases.

Filter by:

NCT ID: NCT05945797 Recruiting - Clinical trials for Common Bile Duct Calculi

Effects of Dexamethasone on Common Bile Duct Cannulation Time

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The main aim of this clinical trial is to evaluate the effects of dexamethasone on common bile duct cannulation time during endoscopic retrograde cholangiopancreatography (ERCP) in patients with biliary pathologies. The study will also study the effects of dexamethasone on total procedure time and total fluoroscopy time during ERCP. Participants will be divided into two groups, treatment group and placebo group. Patients in treatment group will receive dexamethasone and those in placebo group will be given normal saline before undergoing ERCP. The results in both groups will be compared to determine the effects of dexamethasone.

NCT ID: NCT05755607 Not yet recruiting - Pancreatic Cancer Clinical Trials

A Multicenter Prospective Randomized Controlled Study of RPD Versus LPD

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

laparoscopic pancreaticoduodenectomy(LPD) and Robot Pancreaticoduodenectomy (RPD), as two minimally invasive methods of pancreaticoduodenectomy(PD), have obvious advantages over traditional open pancreaticoduodenectomy(OPD) in terms of reducing surgical trauma and hospitalization time, but there are few studies on their perioperative safety and prognostic effects.However, there are few studies on the perioperative safety and prognostic effects of both procedures. In this trial, the perioperative data and prognosis of both procedures were collected and analyzed through a prospective, multicenter approach to investigate the advantages and disadvantages of both procedures.

NCT ID: NCT05755594 Not yet recruiting - Pancreatic Cancer Clinical Trials

A Prospective Study on the Safety and Efficacy of Robot-assisted Pancreaticoduodenectomy

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

Further studies are needed to investigate the prognosis and perioperative safety of patients undergoing robotic-assisted pancreaticoduodenectomy. In this study, clinical data and prognostic data of patients undergoing this procedure were prospectively collected and analyzed to explore its safety and efficacy.

NCT ID: NCT05660915 Recruiting - Pancreatic Cancer Clinical Trials

A Prospective Clinical Study Using an Artery-first Intermediate Approach in Robot-assisted Pancreaticoduodenectomy

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

Pancreaticoduodenectomy, as a standard surgical procedure for malignant tumors of the head of the pancreas, ampulla and distal common bile duct, has brought the hope of clinical cure for these diseases.In the whole surgical process, the resection of the uncinate process of the pancreas is considered to be a major difficulty in the whole operation, which can affect the rehabilitation process and long-term prognosis. Two main methods have been developed around the dissection of the uncinate process of the pancreas. One is the Venous-first approach based on the portal vein-superior mesenteric vein axis. The other is the Artery-first approach that first explores whether the superior mesenteric artery is invaded by the tumor to judge resectable. The latter is gradually promoted in clinical practice because it can reduce intraoperative bleeding, reduce postoperative complications, and improve long-term prognosis. The intermediate approach is a surgical approach based on the Artery-first approach and adapted to the layout of the robot arm. The area between superior mesenteric artery and superior mesenteric vein was used as an intermediate area to treat the uncinate process of the pancreas in order to reduce perioperative complications and achieve better surgical results. However, the safety and effectiveness of intermediate approach have not been verified,in this prospective clinical study, the investigators will use a robotic surgical platform to perform robot-assisted pancreaticoduodenectomy surgery through the intermediate approach to verify its safety and efficacy.

NCT ID: NCT04503200 Not yet recruiting - Clinical trials for Endoscopic Retrograde Cholangiopancreatography

Double Guidewire Technique Versus Transpancreatic Precut in Patients With Repetitive Unintentional Cannulation of the Pancreatic Duct.

Start date: August 15, 2020
Phase: N/A
Study type: Interventional

Difficult cannulation of the common bile duct is encountered in about 10%of ERCP procedures. This frequently happens in the form of repeated unintentional cannulation of the pancreatic duct. Two valid options are available to facilitate cannulation at this point: Double guidewire technique or performing a transpancreatic precut. This is a randomized trial comparing the efficacy and Safety of double guidwire technique versus transpancreatic precut after three unintentional passages of the guidewire into the pancreatic duct.

NCT ID: NCT03595150 Not yet recruiting - Clinical trials for Common Bile Duct Diseases

Diclofenac for Prevention of Post-ERC Pancreatitis

Start date: January 1, 2025
Phase: Phase 2/Phase 3
Study type: Interventional

The study aims at assessing the effectiveness of Diclofenac for prevention of post-ERCP pancreatitis. It will be undertaken embedded in the Swedish national register for Gallstone surgery and ERCP (GallRiks). Patients are randomised to Diclofenac prior to the ERCP or no prophylaxis. GallRiks is used to identify which patients fulfill the eligibility criteria and which patients develop pancreatitis after the ERCP.

NCT ID: NCT03190343 Active, not recruiting - Clinical trials for Biliary Tract Diseases

Assessment of Cholangio-pancreatoscopy for the Diagnosis and the Treatment of Biliary and Pancreatic Diseases

Start date: November 2016
Phase:
Study type: Observational [Patient Registry]

The biliary and pancreatic tumors are rare but the prognosis is pejorative. It was difficult to have histology of these tumors as the samples taken during ERCP were performed under " blind " radiology control. So the diagnostic accuracy was insufficient. The arrival of A new optic fiber endoscope used by only one operator had improved the diagnostic of bilio-pancreatic diseases. However this technology with optic fiber quickly had proved outdated for several reasons: poor manoeuvrability, perfectible optical vision, optical fibers fragility and cost. A new generation of endoscopes with digital vision appeared and would allow an increase in diagnostic accuracy related to better vision and manoeuvrability. The purpose of the study is to assess the interest of the cholangio pancreatoscopy performed with digital vision.

NCT ID: NCT02967926 Completed - Clinical trials for Cholangitis, Sclerosing

Digital SpyGlass Confirmed Common Bile Duct Stones Clearance Without Fluoroscopy

Start date: December 2015
Phase: Phase 3
Study type: Interventional

This study aim to evaluated the effectiveness of Digital SpyGlass Cholangioscopy to facilitate common bile duct stone removal without fluoroscopy

NCT ID: NCT02596646 Terminated - Clinical trials for Common Bile Duct Diseases

Early Precut in Difficult Biliary Cannulation

Start date: January 2012
Phase: N/A
Study type: Interventional

This study evaluates whether an early precut strategy in cases of difficult biliary cannulation could reduce the incidence of PEP compared with that after prolonged cannulation attempts. Secondary aims are to compare the success of biliary cannulation and complications rates of the two techniques.

NCT ID: NCT00840138 Active, not recruiting - Cholecystectomy Clinical Trials

A Comparison of Bile Duct Injuries Following Open Cholecystectomy Versus Laparoscopic Cholecystectomy

Start date: January 1996
Phase: N/A
Study type: Observational

In this prospective study the investigators compared common bile duct injuries (CBDI) following laparoscopic cholecystectomy (LC) and open cholecystectomy (OC) procedures, 35 patients in each group. To date, no detailed study concerning this matter has been published. LC - CBDI in comparison with OC - CBDI more often concerned young females with a narrow CBD, they were located closer to the liver hilus, and they were more extended.